{
  "nctId": "NCT05787808",
  "briefTitle": "Profylactic Treatment for Patients in Risk Osteoporosis",
  "officialTitle": "The Effect on Bone Marker and Body Mineral Density (BMD) of Daily Jarlsberg Cheese Intake in Risk Patient for Osteoporosis",
  "protocolDocument": {
    "nctId": "NCT05787808",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2023-03-09",
    "uploadDate": "2023-03-15T11:23",
    "size": 2133924,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05787808/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 60,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2023-05-02",
    "completionDate": "2025-12-15",
    "primaryCompletionDate": "2025-09-15",
    "firstSubmitDate": "2023-03-15",
    "firstPostDate": "2023-03-28"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Osteopeni patients (OP) of both genders above 55 years of age. OPs are defined as patients with T-score below 0.0 but larger than -2.5.\n\nExclusion Criteria:\n\n* • Eating disorder\n\n  * Known gastrointestinal disorder.\n  * Abnormal liver or kidney function.\n  * Diabetes mellitus type I.\n  * Diabetes type II without sufficient control.\n  * Suffering from verified cancer.\n  * Under systemic treatment with corticosteroids or other immunosuppressive drugs the last 3 weeks before start of the trial treatment.\n  * Under active antiresorptive treatment or anabolic treatment.\n  * Participating in another clinical trial with pharmaceuticals the last six weeks before start of this trial treatment.\n  * Known milk product allergy.\n  * Not able to understand information.\n  * Do not want or not able to give written consent to participate in the study.",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "55 Years",
    "maximumAge": "85 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Bone Mineral Density",
        "description": "g/cm2",
        "timeFrame": "Week 0"
      },
      {
        "measure": "Bone Mineral Density",
        "description": "g/cm2",
        "timeFrame": "Week 16"
      },
      {
        "measure": "Bone Mineral Density",
        "description": "g/cm2",
        "timeFrame": "Week 32"
      },
      {
        "measure": "Bone Mineral Density",
        "description": "g/cm2",
        "timeFrame": "Week 48"
      }
    ],
    "secondary": [
      {
        "measure": "Osteocalcin",
        "description": "ng/ml",
        "timeFrame": "week 0"
      },
      {
        "measure": "Osteocalcin",
        "description": "ng/ml",
        "timeFrame": "week 4"
      },
      {
        "measure": "Osteocalcin",
        "description": "ng/ml",
        "timeFrame": "week 16"
      },
      {
        "measure": "Osteocalcin",
        "description": "ng/ml",
        "timeFrame": "week 20"
      },
      {
        "measure": "Osteocalcin",
        "description": "ng/ml",
        "timeFrame": "week 32"
      },
      {
        "measure": "Osteocalcin",
        "description": "ng/ml",
        "timeFrame": "week 48"
      },
      {
        "measure": "Procollagen type 1 N-terminal propeptide (PINP)",
        "description": "ng/ml",
        "timeFrame": "Week 0"
      },
      {
        "measure": "Procollagen type 1 N-terminal propeptide (PINP)",
        "description": "ng/ml",
        "timeFrame": "Week 4"
      },
      {
        "measure": "Procollagen type 1 N-terminal propeptide (PINP)",
        "description": "ng/ml",
        "timeFrame": "Week 16"
      },
      {
        "measure": "Procollagen type 1 N-terminal propeptide (PINP)",
        "description": "ng/ml",
        "timeFrame": "Week 20"
      },
      {
        "measure": "Procollagen type 1 N-terminal propeptide (PINP)",
        "description": "ng/ml",
        "timeFrame": "Week 32"
      },
      {
        "measure": "Procollagen type 1 N-terminal propeptide (PINP)",
        "description": "ng/ml",
        "timeFrame": "Week 48"
      },
      {
        "measure": "Cross-linked C-telopeptide type I collagen (CTX)",
        "description": "ng/ml",
        "timeFrame": "week 0"
      },
      {
        "measure": "Cross-linked C-telopeptide type I collagen (CTX)",
        "description": "ng/ml",
        "timeFrame": "week 4"
      },
      {
        "measure": "Cross-linked C-telopeptide type I collagen (CTX)",
        "description": "ng/ml",
        "timeFrame": "week 16"
      },
      {
        "measure": "Cross-linked C-telopeptide type I collagen (CTX)",
        "description": "ng/ml",
        "timeFrame": "week 20"
      },
      {
        "measure": "Cross-linked C-telopeptide type I collagen (CTX)",
        "description": "ng/ml",
        "timeFrame": "week 32"
      },
      {
        "measure": "Cross-linked C-telopeptide type I collagen (CTX)",
        "description": "ng/ml",
        "timeFrame": "week 48"
      },
      {
        "measure": "Bone specific ALP (BALB)",
        "description": "ng/ml",
        "timeFrame": "Week 0"
      },
      {
        "measure": "Bone specific ALP (BALB)",
        "description": "ng/ml",
        "timeFrame": "Week 4"
      },
      {
        "measure": "Bone specific ALP (BALB)",
        "description": "ng/ml",
        "timeFrame": "Week 16"
      },
      {
        "measure": "Bone specific ALP (BALB)",
        "description": "ng/ml",
        "timeFrame": "Week 20"
      },
      {
        "measure": "Bone specific ALP (BALB)",
        "description": "ng/ml",
        "timeFrame": "Week 32"
      },
      {
        "measure": "Bone specific ALP (BALB)",
        "description": "ng/ml",
        "timeFrame": "Week 48"
      }
    ],
    "other": [
      {
        "measure": "Vitamin K2",
        "description": "ng/ml",
        "timeFrame": "Week 0"
      },
      {
        "measure": "Vitamin K2",
        "description": "ng/ml",
        "timeFrame": "Week 16"
      },
      {
        "measure": "Vitamin K2",
        "description": "ng/ml",
        "timeFrame": "Week 32"
      },
      {
        "measure": "Vitamin K2",
        "description": "ng/ml",
        "timeFrame": "Week 48"
      },
      {
        "measure": "Interleukin IL-1β, IL6, IL8, IL10",
        "description": "ng/ml",
        "timeFrame": "Week 0"
      },
      {
        "measure": "Interleukin IL-1β, IL6, IL8, IL10",
        "description": "ng/ml",
        "timeFrame": "Week 32"
      },
      {
        "measure": "Interleukin IL-1β, IL6, IL8, IL10",
        "description": "ng/ml",
        "timeFrame": "Week 48"
      },
      {
        "measure": "Cytokine TNF-α, NF-ƙβ (RANK-L), OPG, TGF-β",
        "description": "ng/ml",
        "timeFrame": "Week 0"
      },
      {
        "measure": "Cytokine TNF-α, NF-ƙβ (RANK-L), OPG, TGF-β",
        "description": "ng/ml",
        "timeFrame": "Week 32"
      },
      {
        "measure": "Cytokine TNF-α, NF-ƙβ (RANK-L), OPG, TGF-β",
        "description": "ng/ml",
        "timeFrame": "Week 48"
      }
    ]
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 4,
      "secondaryCount": 24,
      "otherCount": 10,
      "totalCount": 38
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:30:02.371Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}